Long non-coding RNAs and their implications in cancer epigenetics

Bioscience Reports

Volumn 33, Issue 4, 2013, Pages 667-675

  Beckedorff, Felipe C ^a   Sena Amaral, Murilo ^a   Deocesano Pereira, Carlos ^a   Verjovski Almeida, Sergio ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia   (Brazil)

Author keywords

Cancer epigenetics; Intergenic lncRNA; Intronic lncRNA; Long non coding RNAs; Regulatory RNA; RNA guided gene silencing

Indexed keywords

BINDING PROTEIN; CARBOXY TERMINAL BINDING PROTEIN 1; COMPLEMENTARY RNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; HOX PROTEIN; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG; HISTONE; NUCLEOSOME;

ANRASSF1 GENE; ANRIL GENE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GENETICS; CANCER GROWTH; CANCER PROGNOSIS; COLORECTAL CARCINOMA; CTBP1 AS GENE; DNA METHYLATION; DNA RNA HYBRIDIZATION; EPIGENETICS; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MARKER; HISTONE MODIFICATION; HOTAIR GENE; HUMAN; INTRON; LIVER CELL CARCINOMA; NUCLEOSOME; PANCREAS CARCINOMA; PCAT 1 GENE; PROSTATE CANCER; PROTEIN RNA BINDING; REVIEW; RNA ANALYSIS; RNA GENE; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; XIST GENE; ANIMAL; GENE EXPRESSION; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEOPLASM; PROTEIN PROCESSING;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; NEOPLASMS; NUCLEOSOMES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, LONG NONCODING;

EID: 84884834721     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20130054     Document Type: Review

References (78)

1. Crick, F. H., Barnett, L., Brenner, S. and Watts-Tobin, R. J. (1961) General nature of the genetic code for proteins. Nature 192, 1227-1232
2. Kapranov, P., Cawley, S. E., Drenkow, J., Bekiranov, S., Strausberg, R. L., Fodor, S. P. and Gingeras, T. R. (2002) Large-scale transcriptional activity in chromosomes 21 and 22. Science 296, 916-919 (Pubitemid 34464898)
3. Katayama, S., Tomaru, Y., Kasukawa, T., Waki, K., Nakanishi, M., Nakamura, M., Nishida, H., Yap, C. C., Suzuki, M., Kawai, J. et al. (2005) Antisense transcription in the mammalian transcriptome. Science 309, 1564-1566
4. Nakaya, H. I., Amaral, P. P., Louro, R., Lopes, A., Fachel, A. A., Moreira, Y. B., El-Jundi, T. A., da Silva, A. M., Reis, E. M. and Verjovski-Almeida, S. (2007) Genome mapping and expression analyses of human intronic noncoding RNAs reveal tissue-specific patterns and enrichment in genes related to regulation of transcription. Genome Biol. 8, R43
5. Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F. et al. (2012) Landscape of transcription in human cells. Nature 489, 101-108
6. Kapranov, P., Cheng, J., Dike, S., Nix, D. A., Duttagupta, R., Willingham, A. T., Stadler, P. F., Hertel, J., Hackermuller, J., Hofacker, I. L. et al. (2007) RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488 (Pubitemid 46906616)
7. Guttman, M., Amit, I., Garber, M., French, C., Lin, M. F., Feldser, D., Huarte, M., Zuk, O., Carey, B. W., Cassady, J. P. et al. (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227
8. Wang, D., Garcia-Bassets, I., Benner, C., Li, W., Su, X., Zhou, Y., Qiu, J., Liu, W., Kaikkonen, M. U., Ohgi, K. A. et al. (2011) Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474, 390-394
9. St Laurent, G., Shtokalo, D., Tackett, M. R., Yang, Z., Eremina, T., Wahlestedt, C., Urcuqui-Inchima, S., Seilheimer, B., McCaffrey, T. A. and Kapranov, P. (2012) Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells. BMC Genomics 13, 504
10. Louro, R., Smirnova, A. S. and Verjovski-Almeida, S. (2009) Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics 93, 291-298
11. Wang, X., Song, X., Glass, C. K. and Rosenfeld, M. G. (2011) The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs. Cold Spring Harb. Perspect. Biol. 3, a003756
12. Khalil, A. M. and Rinn, J. L. (2011) RNA-protein interactions in human health and disease. Semin. Cell Dev. Biol. 22, 359-365
13. Saxena, A. and Carninci, P. (2011) Long non-coding RNA modifies chromatin: epigenetic silencing by long non-coding RNAs. BioEssays 33, 830-839
14. Mercer, T. R. and Mattick, J. S. (2013) Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 20, 300-307
15. Lee, J. T. (2012) Epigenetic regulation by long noncoding RNAs. Science 338, 1435-1439
16. Timp, W. and Feinberg, A. P. (2013) Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat. Rev. Cancer 13, 497-510
17. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874
18. Spizzo, R., Almeida, M. I., Colombatti, A. and Calin, G. A. (2012) Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31, 4577-4587
19. Gutschner, T. and Diederichs, S. (2012) The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 9, 703-719
20. Nie, L., Wu, H. J., Hsu, J. M., Chang, S. S., Labaff, A. M., Li, C. W., Wang, Y., Hsu, J. L. and Hung, M. C. (2012) Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am. J. Transl. Res. 4, 127-150
21. Reis, E. M., Nakaya, H. I., Louro, R., Canavez, F. C., Flatschart, A. V., Almeida, G. T., Egidio, C. M., Paquola, A. C., Machado, A. A., Festa, F. et al. (2004) Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene 23, 6684-6692 (Pubitemid 39265533)
22. Tahira, A. C., Kubrusly, M. S., Faria, M. F., Dazzani, B., Fonseca, R. S., Maracaja-Coutinho, V., Verjovski-Almeida, S., Machado, M. C. and Reis, E. M. (2011) Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol. Cancer 10, 141
23. Brunner, A. L., Beck, A. H., Edris, B., Sweeney, R. T., Zhu, S. X., Li, R., Montgomery, K., Varma, S., Gilks, T., Guo, X. et al. (2012) Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol. 13, R75
24. Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D. et al. (2011) Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 29, 742-749
25. Lee, G. L., Dobi, A. and Srivastava, S. (2011) Prostate cancer: diagnostic performance of the PCA3 urine test. Nat. Rev. Urol. 8, 123-124
26. Morris, K. V. (2009) Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics 4, 296-301
27. Wang, Y. and Leung, F. C. (2004) An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics 20, 1170-1177 (Pubitemid 38660354)
28. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MECP2 involves a histone deacetylase complex. Nature 393, 386-389 (Pubitemid 28269714)
29. Feinberg, A. P. and Vogelstein, B. (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89-92 (Pubitemid 13154475)
30. Rodriguez, J., Frigola, J., Vendrell, E., Risques, R. A., Fraga, M. F., Morales, C., Moreno, V., Esteller, M., Capella, G., Ribas, M. et al. (2006) Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res. 66, 8462-9468
31. Akiyama, Y., Watkins, N., Suzuki, H., Jair, K. W., van Engeland, M., Esteller, M., Sakai, H., Ren, C. Y., Yuasa, Y., Herman, J. G. et al. (2003) Gata-4 and Gata-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol. Cell Biol. 23, 8429-8439 (Pubitemid 37433351)
32. Li, Q., Su, Z., Xu, X., Liu, G., Song, X., Wang, R., Sui, X., Liu, T., Chang, X. and Huang, D. (2012) AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and trans. Proc. Natl. Acad. Sci. U.S.A. 109, 14110-14115
33. Mohammad, F., Pandey, G. K., Mondal, T., Enroth, S., Redrup, L., Gyllensten, U. and Kanduri, C. (2012) Long noncoding RNA-mediated maintenance of DNA methylation and transcriptional gene silencing. Development 139, 2792-2803
34. Imamura, T., Yamamoto, S., Ohgane, J., Hattori, N., Tanaka, S. and Shiota, K. (2004) Non-coding RNA directed DNA demethylation of SPHK1 CpG island. Biochem. Biophys. Res. Commun. 322, 593-600 (Pubitemid 39490344)
35. Yen, K., Vinayachandran, V., Batta, K., Koerber, R. T. and Pugh, B. F. (2012) Genome-wide nucleosome specificity and directionality of chromatin remodelers. Cell 149, 1461-1473
36. John, S., Sabo, P. J., Thurman, R. E., Sung, M. H., Biddie, S. C., Johnson, T. A., Hager, G. L. and Stamatoyannopoulos, J. A. (2011) Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet 43, 264-268
37. Wilson, B. G. and Roberts, C. W. (2011) SWI/SNF nucleosome remodellers and cancer. Nat. Rev. Cancer 11, 481-492
38. Mulero-Navarro, S. and Esteller, M. (2008) Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancer. Epigenetics 3, 210-215
39. Zhu, Y., Rowley, M. J., Bohmdorfer, G. and Wierzbicki, A. T. (2013) A SWI/SNF chromatin-remodeling complex acts in noncoding RNA-mediated transcriptional silencing. Mol. Cell 49, 298-309
40. Talbert, P. B. and Henikoff, S. (2010) Histone variants-ancient wrap artists of the epigenome. Nat. Rev. Mol. Cell Biol. 11, 264-275
41. Vardabasso, C., Hasson, D., Ratnakumar, K., Chung, C. Y., Duarte, L. F. and Bernstein, E. (2013) Histone variants: emerging players in cancer biology. Cell Mol. Life Sci., doi:10.1007/s00018-013- 1343-z
42. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705 (Pubitemid 46273577)
43. Bannister, A. J. and Kouzarides, T. (2011) Regulation of chromatin by histone modifications. Cell Res. 21, 381-395
44. Ropero, S., Fraga, M. F., Ballestar, E., Hamelin, R., Yamamoto, H., Boix-Chornet, M., Caballero, R., Alaminos, M., Setien, F., Paz, M. F. et al. (2006) A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat. Genet. 38, 566-569
45. Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K. P. and Gottlicher, M. (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5, 455-463 (Pubitemid 38610247)
46. Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K. et al. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37, 391-400
47. Moore, S. D., Herrick, S. R., Ince, T. A., Kleinman, M. S., Dal Cin, P., Morton, C. C. and Quade, B. J. (2004) Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase morf. Cancer Res. 64, 5570-5577 (Pubitemid 39095551)
48. Xu, K., Wu, Z. J., Groner, A. C., He, H. H., Cai, C., Lis, R. T., Wu, X., Stack, E. C., Loda, M., Liu, T. et al. (2012) EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 338, 1465-1469
49. Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R. and Issa, J. P. (2008) Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS ONE 3, e2037
50. Shi, X. B., Xue, L., Yang, J., Ma, A. H., Zhao, J., Xu, M., Tepper, C. G., Evans, C. P., Kung, H. J. and deVere White, R. W. (2007) An androgen-regulated miRNA suppresses bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 104, 19983-19988
51. Lynch, J. T., Harris, W. J. and Somervaille, T. C. (2012) Lsd1 inhibition: a therapeutic strategy in cancer? Expert Opin. Ther. Targets 16, 1239-1249
52. Takayama, K. I., Horie-Inoue, K., Katayama, S., Suzuki, T., Tsutsumi, S., Ikeda, K., Urano, T., Fujimura, T., Takagi, K., Takahashi, S. et al. (2013) Androgen-responsive long noncoding RNA CTBP1-as promotes prostate cancer. EMBO J. 32, 1665-1680
53. Louro, R., Nakaya, H. I., Amaral, P. P., Festa, F., Sogayar, M. C., da Silva, A. M., Verjovski-Almeida, S. and Reis, E. M. (2007) Androgen responsive intronic non-coding RNAs. BMC Biol. 5, 4
54. Pasmant, E., Laurendeau, I., Heron, D., Vidaud, M., Vidaud, D. and Bieche, I. (2007) Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963-3969 (Pubitemid 46762186)
55. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, III, R. S., Johnson, B. E. and Skolnick, M. H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440
56. Serrano, M., Hannon, G. J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin d/CDK4. Nature 366, 704-707 (Pubitemid 24036021)
57. Popov, N. and Gil, J. (2010) Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 5, 685-690
58. Folkersen, L., Kyriakou, T., Goel, A., Peden, J., Malarstig, A., Paulsson-Berne, G., Hamsten, A., Hugh, W., Franco-Cereceda, A., Gabrielsen, A. et al. (2009) Relationship between cad risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS ONE 4, e7677
59. Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A. P. and Cui, H. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202-206
60. Yap, K. L., Li, S., Munoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S., Gil, J., Walsh, M. J. and Zhou, M. M. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine by Polycomb cbx7 in transcriptional silencing of INK4a. Mol. Cell 38, 662-674
61. Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M. and Xiong, Y. (2011) Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4b) tumor suppressor gene. Oncogene 30, 1956-1962
62. Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E. et al. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323 (Pubitemid 46962090)
63. Tsai, M. C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E. and Chang, H. Y. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693
64. Chu, C., Qu, K., Zhong, F. L., Artandi, S. E. and Chang, H. Y. (2011) Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol. Cell 44, 667-678
65. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M. C., Hung, T., Argani, P., Rinn, J. L. et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076
66. Yang, Z., Zhou, L., Wu, L. M., Lai, M. C., Xie, H. Y., Zhang, F. and Zheng, S. S. (2011) Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 18, 1243-1250
67. Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S. and Safe, S. (2013) HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32, 1616-1625
68. Wang, L., Zeng, X., Chen, S., Ding, L., Zhong, J., Zhao, J. C., Wang, L., Sarver, A., Koller, A., Zhi, J. et al. (2013) BRCA1 is a negative modulator of the PRC2 complex. EMBO J. 32, 1584-1597
69. Ge, X., Chen, Y., Liao, X., Liu, D., Li, F., Ruan, H. and Jia, W. (2013) Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med. Oncol. 30, 588
70. Beckedorff, F. C., Ayupe, A. C., Crocci-Souza, R., Amaral, M. S., Nakaya, H. I., Soltys, D. T., Menck, C. F. M., Reis, E. M. and Verjovski-Almeida, S. (2013) The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet. 9, e1003705
71. Yildirim, E., Kirby, J. E., Brown, D. E., Mercier, F. E., Sadreyev, R. I., Scadden, D. T. and Lee, J. T. (2013) Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 152, 727-742
72. Froberg, J. E., Yang, L. and Lee, J. T. (2013) Guided by RNAs: X-inactivation as a model for lncRNA function. J. Mol. Biol., doi:10.1016/j.jmb.2013.06.031
73. Du, Z., Fei, T., Verhaak, R. G., Su, Z., Zhang, Y., Brown, M., Chen, Y. and Liu, X. S. (2013) Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Mol. Biol. 20, 908-913
74. Wahlestedt, C. (2013) Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat. Rev. Drug Discov. 12, 433-446
75. Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M. et al. (2009) The human colon cancer methylome shows similar hypoand hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186
76. Doi, A., Park, I. H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S. et al. (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350-1353
77. Brentani, H., Caballero, O. L., Camargo, A. A., da Silva, A. M., da Silva, Jr, W. A., Dias Neto, E., Grivet, M., Gruber, A., Guimaraes, P. E., Hide, W. et al. (2003) The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc. Natl. Acad. Sci. U.S.A. 100, 13418-13423 (Pubitemid 37444757)
78. Wang, K. C., Yang, Y. W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y., Lajoie, B. R., Protacio, A., Flynn, R. A., Gupta, R. A. et al. (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472, 120-124